Search

everythinglearnresearchcommunity

for

Search:↓

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

Regulatory T-cells are important for healing and regenerating tissues in various organs by controlling immune responses and aiding stem cells.

People with acne have more CD4+ immune cells in their skin than healthy people.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

γδ T cells adapt uniquely to different tissues in mice.

CD25+ CD4+ Tregs and certain plasma proteins are linked to hair loss.

Pentoxifylline alone and combined with triamcinolone acetonide is effective for treating localized alopecia areata, with the combination showing the highest effectiveness.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

A dissolving microneedle patch with collagen XVII effectively promotes hair regrowth in androgenic alopecia.

IL-25 helps heal diabetic wounds by improving blood vessel and skin cell functions.

New anti-acne medications are being tested to offer alternatives to current treatments.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

17-beta estradiol and prednisolone may help regrow hair damaged by chemotherapy.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

IL-15 promotes hair growth and protects hair follicles.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Special immune cells called Treg cells are important for maintaining and regenerating hair by activating a specific growth signal in hair stem cells.

Targeting the Smoothened receptor shows promise for treating certain cancers.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Advanced therapy medicinal products show promise for vitiligo treatment with fewer side effects, but affordability is a challenge.